SD Biosensor

Public agencies in over 100 LMICs will be able to buy SD Biosensor’s STANDARD Q HIV/Syphilis Combo test for less than $1 through a collaboration between the company, the Clinton Health Access Initiative (CHAI) and Britain’s MedAccess, the partners announced Monday.

A volume guarantee agreement between MedAccess and the South Korean manufacturer will make the WHO-prequalified diagnostic available to a cohort of countries bearing 98% of the global burden of congenital syphilis and 93% of…

As the United States eclipsed China in confirmed cases, more vaccines neared human trials and funders made over $330 million in new commitments to fight Covid-19.

The week’s noteworthy developments included:


On vaccines, the University of Oxford announced today that it has begun recruiting volunteers for clinical trials—set to begin in weeks—of ChAdOx1 nCov-19, its adenovirus vector-based shot.

Sanofi announced today a collaboration with Massachusetts…

Korea’s Research Investment for Global Health Technology (RIGHT) Fund announced its first four recipients of $5.8 million in grants last week at its 2019 investment forum.

EuBiologics (with Seoul’s International Vaccine Institute, Massachusetts General Hospital and Harvard Medical School) won support for its preclinical cholera conjugate vaccine.

SK Biotek (with the Medicines for Malaria Venture) will get funding for continuous process development and scale-up of new malaria…